相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
Nick S. Nurmohamed et al.
CARDIOVASCULAR RESEARCH (2022)
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis Distinguishing Between Particle Concentration, Type, and Content
Nicholas A. Marston et al.
JAMA CARDIOLOGY (2022)
Low-density lipoprotein cholesterol/apolipoprotein B ratio is superior to apolipoprotein B alone in the diagnosis of coronary artery calcification
Tsui-Yen Chang et al.
CORONARY ARTERY DISEASE (2021)
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
Hiroaki Ikezaki et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Per-Particle Triglyceride-Rich Lipoproteins Imply Higher Myocardial Infarction Risk Than Low-Density Lipoproteins Copenhagen General Population Study
Mia O. Johansen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease
Heinz Drexel et al.
ATHEROSCLEROSIS (2021)
Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population Study
Mie Balling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins
Mie Balling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis
Lathan Liou et al.
PLOS ONE (2020)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
Allan D. Sniderman et al.
JOURNAL OF LIPID RESEARCH (2018)
Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile
Anastasiya M. Kaneva et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2017)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease
Paul T. Williams et al.
ATHEROSCLEROSIS (2014)
Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study
Sarah Parish et al.
CIRCULATION (2012)
The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease
JoAnn E. Manson et al.
CONTEMPORARY CLINICAL TRIALS (2012)
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Samia Mora et al.
CIRCULATION (2009)
The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine
Paul Elliott et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men -: 13-year follow-up data from the Quebec Cardiovascular Study
AC St-Pierre et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A novel and simple method for quantification of small, dense LDL
T Hirano et al.
JOURNAL OF LIPID RESEARCH (2003)
Hypertriglyceridemic hyperapoB: The unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus
AD Sniderman et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
